Stocktoria
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL
NYSE · XNYS · stock · Services-Commercial Physical & Biological Research · website · IPO 2000-06-23
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | 0.6% | 5.6% | 14.9% | 16.4% | 16.7% |
| Net margin | -3.6% | 0.5% | 11.5% | 12.2% | 11.0% |
| Return on assets | -2.0% | 0.3% | 5.8% | 6.4% | 5.6% |
| Return on equity | -4.6% | 0.6% | 13.2% | 16.3% | 15.4% |
| Current ratio | 1.29 | 1.41 | 1.52 | 1.32 | 1.23 |
| Revenue growth | -0.9% | -1.9% | 3.9% | 12.3% | 21.1% |
Source: SEC EDGAR filings · CIK 0001100682 · as of 2025-12-27. Facts from filings plus Stocktoria's own computed scores — not investment advice.